| Literature DB >> 23346379 |
O S Petrakova1, V V Ashapkin, E A Voroteliak, E Y Bragin, V Y Shtratnikova, E S Chernioglo, Y V Sukhanov, V V Terskikh, A V Vasiliev.
Abstract
Cellular therapy of endodermal organs is one of the most important issues in modern cellular biology and biotechnology. One of the most promising directions in this field is the study of the transdifferentiation abilities of cells within the same germ layer. A method for anin vitroinvestigation of the cell differentiation potential (the cell culture in a three-dimensional matrix) is described in this article. Cell cultures of postnatal salivary gland cells and postnatal liver progenitor cells were obtained; their comparative analysis under 2D and 3D cultivation conditions was carried out. Both cell types have high proliferative abilities and can be cultivated for more than 20 passages. Under 2D cultivation conditions, the cells remain in an undifferentiated state. Under 3D conditions, they undergo differentiation, which was confirmed by a lower cell proliferation and by an increase in the differentiation marker expression. Salivary gland cells can undergo hepatic and pancreatic differentiation under 3D cultivation conditions. Liver progenitor cells also acquire a pancreatic differentiation capability under conditions of 3D cultivation. Thus, postnatal salivary gland cells exhibit a considerable differentiation potential within the endodermal germ layer and can be used as a promising source of endodermal cells for the cellular therapy of liver pathologies. Cultivation of cells under 3D conditions is a useful model for thein vitroanalysis of the cell differentiation potential.Entities:
Keywords: 3D conditions; collagen gel; differentiation; endoderm; liver progenitor cells; submandibular salivary gland cells
Year: 2012 PMID: 23346379 PMCID: PMC3548173
Source DB: PubMed Journal: Acta Naturae ISSN: 2075-8251 Impact factor: 1.845
Antibodies used in the present work
| Antibody | Antigen | Company, catalog number |
|---|---|---|
| Primary antibodies | ||
| CK19 | Cytokeratin 19 | AbCam, # ab15463-1 |
| ALB | Albumin | R & D, # MAB1455 |
| CYP P450 | Cytochrome P450 1A1 | Millipore, # AB1258 |
| BrdU | Bromodeoxyuridine | AbCam, # ab8152 |
| Secondary antibodies | ||
| Alexa Fluor® 488 donkey anti-rabbit IgG (H + L) | Invitrogen, # A-21206 | |
| Alexa Fluor® 488 goat anti-mouse IgG (H + L) | Invitrogen, # A-11029 | |
Primers used in RT-PCR
| Primer | Gene | Nucleotide sequence | Amplicon, bp | Melting temperature, °C |
|---|---|---|---|---|
| mGAPDH | Glyceraldehyde-3-phosphate | 5’-AGG TCG GTG TGA ACG GAT TTG-3’ 5’-GGG GTC GTT GAT GGC AAC A-3’ | 95 | 62.6 62.6 |
| mKRT8 | Keratin 8 | 5’-TCC ATC AGG GTG ACT CAG AAA-3’ 5’-AAG GGG CTC AAC AGG CTC T-3’ | 242 | 60.1 60.0 |
| mKRT14 | Keratin 14 | 5’-GGC TGG AGC AGG AGA TCG CCA-3’ 5’-AGG ACC TGC TCG TGG GTG GAG ACCA-3’ | 90 | 61.0 62.0 |
| mKRT19 | Keratin 19 | 5’-GGG GGT TCA GTA CGC ATT GG-3’ 5’-GAG GAC GAG GTC ACG AAG C-3’ | 113 | 62.9 62.1 |
| mAFP | Alpha fetoprotein | 5’-CCA TCA CCT TTA CCC AGT TTG T-3’ 5’-CCC ATC GCC AGA GTT TTT CTT-3’ | 101 | 60.2 60.6 |
| m1AAT | Alpha-1-antitrypsin | 5’-CTC GTC CGC TCA CTA AAC AAG-3’ 5’-GCT GTC TGA GAG TCA AGG TCT T-3’ | 248 | 60.7 61.3 |
| mTAT | Tyrosine aminotransferase | 5’-AGC CGA ATC CGA ACA AAA CC-3’ 5’-GCC GAT AGA TGG GGC ATA GC-3’ | 146 | 60.9 61.3 |
| mPEPCK | Phosphoenolpyruvate carboxykinase 1 | 5’-TGA CAG ACT CGC CCT ATG TG-3’ 5’-CCC AGT TGT TGA CCA AAG GC-3’ | 153 | 61.0 61.4 |
| mALB | Albumin | 5’-TGC TTT TTC CAG GGG TGT GTT-3’ 5’-TTA CTT CCT GCA CTA ATT TGG CA-3’ | 167 | 62.4 60.2 |
| mCYP3A13 | Cytochrome P450, family 3, subfamily a, polypeptide 13 | 5’-ATG AGG CAG GGA TTA GGA GAA G-3’ 5’-TGA GAG GAA CAG TGG ATC AAA GA-3’ | 189 | 60.7 60.7 |
| mIns2 | Insulin-2 preproprotein | 5’-GCT TCT TCT ACA CAC CCA TGT C-3’ 5’-AGC ACT GAT CTA CAA TGC CAC-3’ | 147 | 60.6 60.1 |
| mAmy | Amylase | 5’-AAC GAA AGA GAA ATT GAA ACC-3’ 5’-GCC CCC ACT CCA CAC ATG TGG-3’ | 213 | 60.0 62.0 |
Primers used in real-time PCR
| Primer | Gene | Nucleotide sequence | Amplicon, bp | Melting temperature, °C |
|---|---|---|---|---|
| mGAPDH | Glyceraldehyde-3-phosphate | 5’-AGG TCG GTG TGA ACG GAT TTG-3’ 5’-GGG GTC GTT GAT GGC AAC A-3’ | 95 | 62.6 62.6 |
| mKRT19 | Keratin 19 | 5’-GGG GGT TCA GTA CGC ATT GG-3’ 5’-GAG GAC GAG GTC ACG AAG C-3’ | 113 | 62.9 62.1 |
| mAFP | Alpha fetoprotein | 5’-CCA TCA CCT TTA CCC AGT TTG T-3’ 5’-CCC ATC GCC AGA GTT TTT CTT-3’ | 101 | 60.2 60.6 |
| m1AAT | Alpha-1-antitrypsin | 5’-CTC GTC CGC TCA CTA AAC AAG-3’ 5’-GCT GTC TGA GAG TCA AGG TCT T-3’ | 248 | 60.7 61.3 |
| mTAT | Tyrosine aminotransferase | 5’-AGC CGA ATC CGA ACA AAA CC-3’ 5’-GCC GAT AGA TGG GGC ATA GC-3’ | 146 | 60.9 61.3 |
| mPEPCK | Phosphoenolpyruvate carboxykinase 1 | 5’-TGA CAG ACT CGC CCT ATG TG-3’ 5’-CCC AGT TGT TGA CCA AAG GC-3’ | 153 | 61.0 61.4 |
RT-PCR for PSGCs and PLPCs during the 1 st passage under 2D and 3D cultivation conditions*
| Primer | 2D conditions | 3D conditions, 10thday | |
|---|---|---|---|
| PSGC | PLPC | PSGC | |
| mGAPDH | 1 | 1 | 1 |
| mKRT19 | 14.1 | 295.59 | 7.9 |
| mAFP | 0.01 | 0.12 | 1.19 |
| m1AAT | 0.04 | 0.30 | 3.19 |
| mTAT | 0.09 | 0.43 | 0.32 |
| mPEPCK | 0.02 | 0.08 | 0.18 |
* The data have been standardized with respect to GAPDH